Navigating the Dodecapeptide Library: A Guide to High-Affinity Ligand Discovery
A dodecapeptide library consists of all possible 12-amino-acid peptides, chemically synthesized and displayed on phage particles. It is crucial for molecular recognition, drug target discovery, and diagnostic/therapeutic tool development. Selected peptides can act as probes for target binding sites or as lead compounds for drug development. Their low molecular weight, high tissue penetration, ease of synthesis, and low immunogenicity offer advantages over antibodies.
Screening Principle
Phage display links each peptide’s phenotype (displayed on the phage surface) with its genotype (encoded internally). This allows in vitro selection of binding peptides, followed by DNA sequencing to identify their sequences. Through repeated biopanning rounds (binding, washing, elution, amplification), phages displaying high-affinity peptides are enriched.
Screening Methods
Three primary methods exist:
Solid-phase panning
Immobilized target protein on a surface. Simple but may alter protein conformation.
Solution-phase panning
Target is biotinylated in solution, and complexes are captured with streptavidin beads. Preserves native protein conformation.
Cell-based panning
Library is incubated with live cells expressing the target receptor. Ideal for membrane proteins in their native environment.
Common Targets
(i) Recombinant extracellular domains of membrane proteins.
(ii) Neutralizing antibodies (selected peptides may mimic natural ligands).
(iii) Whole cells (for unknown targets or hard-to-purify membrane proteins).
Screening Process
(i) Binding: Library is incubated with the immobilized target.
(ii) Washing: Non-specific or weak binders are removed.
(iii) Elution: Specifically bound phages are recovered.
(iv) Amplification: Eluted phages are amplified for subsequent rounds (typically 3-5).
(v) Analysis: Enriched library is sequenced to identify dominant peptide sequences.
(vi) Validation: Lead peptides are synthesized and their affinity (e.g., KD, EC50) is validated via SPR, BLI, or ELISA.
Alpha Lifetech utilizes its phage display platform to construct pre-made dodecapeptide libraries with ultra-high throughput capacity, achieving library sizes up to 10^13/mL. Through multiple rounds of the “Adsorption-Wash-Elution-Amplification” biopanning process, we rapidly enrich peptide sequences that specifically bind to your target molecule. Furthermore, we offer a comprehensive suite of downstream validation services—including, but not limited to, Affinity and Binding Specificity Assays such as SPR, BLI and ELISA—delivering an integrated service package from early-stage screening to lead compound identification to accelerate your research and development progress.